{
  "Version": 79,
  "ExpressionProfiles": [
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "AADAC",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "AADAC|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "AADAC|Relative expression in blood cells",
          "Value": 3.9102564103E-05
        },
        {
          "Path": "AADAC|Relative expression in plasma",
          "Value": 3.9102564103E-05
        },
        {
          "Path": "AADAC|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "AADAC|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Bone|Intracellular|AADAC|Relative expression",
          "Value": 4.8717948718E-05
        },
        {
          "Path": "Organism|Brain|Intracellular|AADAC|Relative expression",
          "Value": 3.9743589744E-05
        },
        {
          "Path": "Organism|Gonads|Intracellular|AADAC|Relative expression",
          "Value": 0.0011923076923
        },
        {
          "Path": "Organism|Heart|Intracellular|AADAC|Relative expression",
          "Value": 0.0026602564103
        },
        {
          "Path": "Organism|Kidney|Intracellular|AADAC|Relative expression",
          "Value": 5.7051282051E-05
        },
        {
          "Path": "Organism|LargeIntestine|Intracellular|AADAC|Relative expression",
          "Value": 0.00010384615385
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Relative expression",
          "Value": 0.00010384615385
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Relative expression",
          "Value": 0.00010384615385
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Relative expression",
          "Value": 0.00010384615385
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Relative expression",
          "Value": 0.00010384615385
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|AADAC|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|AADAC|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|AADAC|Relative expression",
          "Value": 0.0269230769
        },
        {
          "Path": "Organism|Muscle|Intracellular|AADAC|Relative expression",
          "Value": 0.00020833333333
        },
        {
          "Path": "Organism|Pancreas|Intracellular|AADAC|Relative expression",
          "Value": 0.1474358974
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Relative expression",
          "Value": 0.2544871795
        },
        {
          "Path": "Organism|Spleen|Intracellular|AADAC|Relative expression",
          "Value": 0.00037115384615
        },
        {
          "Path": "Organism|Stomach|Intracellular|AADAC|Relative expression",
          "Value": 0.0775641026
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome"
    },
    {
      "Type": "OtherProtein",
      "Species": "Human",
      "Molecule": "ATP1A2",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "ATP1A2|Reference concentration",
          "Value": 0.39140774,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "ATP1A2|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "ATP1A2|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Bone|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0062154033171
        },
        {
          "Path": "Organism|Brain|Intracellular|ATP1A2|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Gonads|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0508741242
        },
        {
          "Path": "Organism|Heart|Intracellular|ATP1A2|Relative expression",
          "Value": 0.3179118843
        },
        {
          "Path": "Organism|Kidney|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0158938619
        },
        {
          "Path": "Organism|LargeIntestine|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0786998764
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0786998764
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0786998764
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0786998764
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0786998764
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0223784807
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0223784807
        },
        {
          "Path": "Organism|Lung|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0272345453
        },
        {
          "Path": "Organism|Muscle|Intracellular|ATP1A2|Relative expression",
          "Value": 0.7034193524
        },
        {
          "Path": "Organism|Pancreas|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0073903254795
        },
        {
          "Path": "Organism|Skin|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0389467988
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0501579923
        },
        {
          "Path": "Organism|Spleen|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0103243118
        },
        {
          "Path": "Organism|Stomach|Intracellular|ATP1A2|Relative expression",
          "Value": 0.0309435884
        }
      ],
      "Localization": "Interstitial, BloodCellsMembrane, VascMembranePlasmaSide"
    },
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "CYP3A4",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "CYP3A4|Reference concentration",
          "Value": 4.32,
          "Unit": "µmol/l"
        },
        {
          "Path": "CYP3A4|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "CYP3A4|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Organism|Brain|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0041682898325
        },
        {
          "Path": "Organism|Gonads|Intracellular|CYP3A4|Relative expression",
          "Value": 0.00078691079081
        },
        {
          "Path": "Organism|Kidney|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0053603428126
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|CYP3A4|Relative expression",
          "Value": 0.00042695753798
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression",
          "Value": 0.0727697702
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome",
      "Ontogeny": {
        "Name": "CYP3A4"
      }
    },
    {
      "Type": "OtherProtein",
      "Species": "Human",
      "Molecule": "GABRG2",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "GABRG2|Reference concentration",
          "Value": 1.04099689,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "GABRG2|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "GABRG2|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Brain|Intracellular|GABRG2|Relative expression",
          "Value": 1.0
        }
      ],
      "Localization": "Interstitial, BloodCellsMembrane, VascMembranePlasmaSide"
    },
    {
      "Type": "Transporter",
      "Species": "Human",
      "Molecule": "OATP1B1",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "OATP1B1|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "OATP1B1|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "OATP1B1|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Brain|Intracellular|OATP1B1|Relative expression",
          "Value": 0.00014166666667
        },
        {
          "Path": "Organism|Gonads|Intracellular|OATP1B1|Relative expression",
          "Value": 0.0141666667
        },
        {
          "Path": "Organism|Heart|Intracellular|OATP1B1|Relative expression",
          "Value": 0.0008253968254
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|OATP1B1|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|OATP1B1|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|OATP1B1|Relative expression",
          "Value": 4.0079365079E-05
        },
        {
          "Path": "Organism|Muscle|Intracellular|OATP1B1|Relative expression",
          "Value": 0.00064682539683
        }
      ],
      "TransportType": "Influx",
      "Expression": [
        {
          "Name": "Bone",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Brain",
          "TransportDirection": "InfluxBrainPlasmaToInterstitial",
          "CompartmentName": "Plasma"
        },
        {
          "Name": "Brain",
          "TransportDirection": "InfluxBrainInterstitialToTissue",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Fat",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Gonads",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Heart",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Kidney",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Kidney",
          "TransportDirection": "ExcretionKidney",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Stomach",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "SmallIntestine",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Duodenum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Duodenum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "UpperJejunum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "UpperJejunum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LowerJejunum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "LowerJejunum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "UpperIleum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "UpperIleum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LowerIleum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "LowerIleum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LargeIntestine",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Caecum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Caecum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonAscendens",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonAscendens",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonTransversum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonTransversum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonDescendens",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonDescendens",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonSigmoid",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonSigmoid",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Rectum",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Rectum",
          "TransportDirection": "InfluxLumenToMucosaIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Periportal",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Periportal",
          "TransportDirection": "ExcretionLiver",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Pericentral",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Pericentral",
          "TransportDirection": "ExcretionLiver",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Lung",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Muscle",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Pancreas",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Skin",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Spleen",
          "TransportDirection": "InfluxInterstitialToIntracellular",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "BloodCells",
          "TransportDirection": "InfluxPlasmaToBloodCells"
        },
        {
          "Name": "VascularEndothelium",
          "TransportDirection": "InfluxPlasmaToInterstitial"
        }
      ]
    },
    {
      "Type": "Transporter",
      "Species": "Human",
      "Molecule": "P-gp",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "Organism|Bone|Intracellular|P-gp|Relative expression",
          "Value": 0.0242518189
        },
        {
          "Path": "Organism|Brain|Intracellular|P-gp|Relative expression",
          "Value": 0.07608904
        },
        {
          "Path": "Organism|Gonads|Intracellular|P-gp|Relative expression",
          "Value": 0.017417973
        },
        {
          "Path": "Organism|Heart|Intracellular|P-gp|Relative expression",
          "Value": 0.0419198106
        },
        {
          "Path": "Organism|Kidney|Intracellular|P-gp|Relative expression",
          "Value": 0.7092198582
        },
        {
          "Path": "Organism|LargeIntestine|Intracellular|P-gp|Relative expression",
          "Value": 0.1108416465
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|P-gp|Relative expression",
          "Value": 0.3971631206
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|P-gp|Relative expression",
          "Value": 0.3971631206
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|P-gp|Relative expression",
          "Value": 0.3971631206
        },
        {
          "Path": "Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|P-gp|Relative expression",
          "Value": 0.3971631206
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|P-gp|Relative expression",
          "Value": 0.1916810428
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|P-gp|Relative expression",
          "Value": 0.1916810428
        },
        {
          "Path": "Organism|Lung|Intracellular|P-gp|Relative expression",
          "Value": 0.0657549316
        },
        {
          "Path": "Organism|Muscle|Intracellular|P-gp|Relative expression",
          "Value": 0.0128342959
        },
        {
          "Path": "Organism|Pancreas|Intracellular|P-gp|Relative expression",
          "Value": 0.0142510689
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|P-gp|Relative expression",
          "Value": 0.2808543974
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|P-gp|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|P-gp|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|P-gp|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|P-gp|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|P-gp|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Spleen|Intracellular|P-gp|Relative expression",
          "Value": 0.0742555691
        },
        {
          "Path": "Organism|Stomach|Intracellular|P-gp|Relative expression",
          "Value": 0.0260852897
        },
        {
          "Path": "P-gp|Reference concentration",
          "Value": 1.41,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "P-gp|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "P-gp|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        }
      ],
      "TransportType": "Efflux",
      "Expression": [
        {
          "Name": "Bone",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Brain",
          "TransportDirection": "EffluxBrainInterstitialToPlasma",
          "CompartmentName": "Plasma"
        },
        {
          "Name": "Brain",
          "TransportDirection": "EffluxBrainTissueToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Fat",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Gonads",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Heart",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Kidney",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Kidney",
          "TransportDirection": "ExcretionKidney",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Stomach",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "SmallIntestine",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Duodenum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Duodenum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "UpperJejunum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "UpperJejunum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LowerJejunum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "LowerJejunum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "UpperIleum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "UpperIleum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LowerIleum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "LowerIleum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "LargeIntestine",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Caecum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Caecum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonAscendens",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonAscendens",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonTransversum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonTransversum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonDescendens",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonDescendens",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "ColonSigmoid",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "ColonSigmoid",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Rectum",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Rectum",
          "TransportDirection": "EffluxMucosaIntracellularToLumen",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Periportal",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Periportal",
          "TransportDirection": "ExcretionLiver",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Pericentral",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Interstitial"
        },
        {
          "Name": "Pericentral",
          "TransportDirection": "ExcretionLiver",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Lung",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Muscle",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Pancreas",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Skin",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "Spleen",
          "TransportDirection": "EffluxIntracellularToInterstitial",
          "CompartmentName": "Intracellular"
        },
        {
          "Name": "BloodCells",
          "TransportDirection": "EffluxBloodCellsToPlasma"
        },
        {
          "Name": "VascularEndothelium",
          "TransportDirection": "EffluxInterstitialToPlasma"
        }
      ],
      "Ontogeny": {
        "Name": "P-gp",
        "Table": {
          "Name": "TableFormula",
          "Percentile": 0.0,
          "DistributionMetaData": [
            {
              "Mean": 1E-14,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 1.915059E-05,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 5.486795E-05,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.0001571905,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.0004502473,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.001288958,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.00368424,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.01048397,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.02946235,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.0800178,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.1994918,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.4165768,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.6716791,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.8542612,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.943803,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9796414,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.992799,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9974749,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9991173,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9996917,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9998924,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9999624,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 0.9999869,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            },
            {
              "Mean": 1.0,
              "Deviation": 1.6,
              "Distribution": "LogNormal"
            }
          ],
          "XName": "Postmenstrual age",
          "XDimension": "Age in years",
          "XUnit": "year(s)",
          "YName": "P-gp",
          "YDimension": "Fraction",
          "UseDerivedValues": false,
          "Points": [
            {
              "X": 0.0,
              "Y": 1E-14,
              "RestartSolver": false
            },
            {
              "X": 0.08333334,
              "Y": 1.915059E-05,
              "RestartSolver": false
            },
            {
              "X": 0.1666667,
              "Y": 5.486795E-05,
              "RestartSolver": false
            },
            {
              "X": 0.25,
              "Y": 0.0001571905,
              "RestartSolver": false
            },
            {
              "X": 0.3333333,
              "Y": 0.0004502473,
              "RestartSolver": false
            },
            {
              "X": 0.4166667,
              "Y": 0.001288958,
              "RestartSolver": false
            },
            {
              "X": 0.5,
              "Y": 0.00368424,
              "RestartSolver": false
            },
            {
              "X": 0.5833333,
              "Y": 0.01048397,
              "RestartSolver": false
            },
            {
              "X": 0.6666667,
              "Y": 0.02946235,
              "RestartSolver": false
            },
            {
              "X": 0.75,
              "Y": 0.0800178,
              "RestartSolver": false
            },
            {
              "X": 0.8333333,
              "Y": 0.1994918,
              "RestartSolver": false
            },
            {
              "X": 0.9166667,
              "Y": 0.4165768,
              "RestartSolver": false
            },
            {
              "X": 1.0,
              "Y": 0.6716791,
              "RestartSolver": false
            },
            {
              "X": 1.083333,
              "Y": 0.8542612,
              "RestartSolver": false
            },
            {
              "X": 1.166667,
              "Y": 0.943803,
              "RestartSolver": false
            },
            {
              "X": 1.25,
              "Y": 0.9796414,
              "RestartSolver": false
            },
            {
              "X": 1.333333,
              "Y": 0.992799,
              "RestartSolver": false
            },
            {
              "X": 1.416667,
              "Y": 0.9974749,
              "RestartSolver": false
            },
            {
              "X": 1.5,
              "Y": 0.9991173,
              "RestartSolver": false
            },
            {
              "X": 1.583333,
              "Y": 0.9996917,
              "RestartSolver": false
            },
            {
              "X": 1.666667,
              "Y": 0.9998924,
              "RestartSolver": false
            },
            {
              "X": 1.75,
              "Y": 0.9999624,
              "RestartSolver": false
            },
            {
              "X": 1.833333,
              "Y": 0.9999869,
              "RestartSolver": false
            },
            {
              "X": 3.333333,
              "Y": 1.0,
              "RestartSolver": false
            }
          ]
        }
      }
    },
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "UGT1A4",
      "Category": "European (P-gp modified, CYP3A4 36 h)",
      "Parameters": [
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|UGT1A4|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|UGT1A4|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "UGT1A4|Reference concentration",
          "Value": 2.32,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "UGT1A4|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "UGT1A4|t1/2 (liver)",
          "Value": 36.0,
          "Unit": "h"
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome",
      "Ontogeny": {
        "Name": "UGT1A4"
      }
    }
  ],
  "Individuals": [
    {
      "Name": "European (P-gp modified, CYP3A4 36 h)",
      "Seed": 17189110,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Parameters": [
        {
          "Path": "Organism|Liver|EHC continuous fraction",
          "Value": 1.0,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "ExpressionProfiles": [
        "AADAC|Human|European (P-gp modified, CYP3A4 36 h)",
        "ATP1A2|Human|European (P-gp modified, CYP3A4 36 h)",
        "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)",
        "GABRG2|Human|European (P-gp modified, CYP3A4 36 h)",
        "OATP1B1|Human|European (P-gp modified, CYP3A4 36 h)",
        "P-gp|Human|European (P-gp modified, CYP3A4 36 h)",
        "UGT1A4|Human|European (P-gp modified, CYP3A4 36 h)"
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Rifampicin",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.5,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Templeton 2011",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 17.0,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Templeton 2011 (equilibrium dialysis)"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 2800.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Boman 1974"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Boman 1974"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 1.24E-05,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 7.9,
          "ValueOrigin": {
            "Source": "Database",
            "Description": "DrugBank DB01045"
          }
        },
        {
          "Type": "Acid",
          "Pka": 1.7,
          "ValueOrigin": {
            "Source": "Database",
            "Description": "DrugBank DB01045"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationSpecific_MM",
          "DataSource": "Nakajima 2011",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "Enzyme concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 6.5,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 195.1,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 9.865,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Collett 2004",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 60.0,
              "Unit": "nmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 2.87,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 55.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 0.6088,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Tirona 2003",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 109.6,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 0.372,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 1.5,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 5.21004653,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "GFR",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Kajosaari 2005",
          "Molecule": "CYP2C8",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 30.2,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Kajosaari et al. 2005"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "CYP2C9",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 150.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Yoshida 2012"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Kajosaari 2005",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 18.5,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Kajosaari et al. 2005"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "BCRP",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 14.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Prueksaritanont 2014"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 0.29,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Bi 2019"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "OATP1B3",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 0.5,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Bi 2019"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "OATP2B1",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 78.2,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Zhang 2019"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Hanke 2021",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 9.1,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Other",
                "Method": "InVitro",
                "Description": "NBI"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Chen 2010",
          "Molecule": "CYP1A2",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l"
            },
            {
              "Name": "Emax",
              "Value": 0.65
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Buckley 2014",
          "Molecule": "CYP2C8",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton IE, Houston JB, Galetin A. Predictive utility of in vitro rifampin induction data generated in fresh and cryopreserved human hepatocytes, Fa2N-4, and HepaRG cells. Drug Metab Dispos. 2011;39:1921–9; Shou M, Hayashi M, Pan Y, Xu Y, Morrissey K, Xu L, et al. Modeling, prediction, and in vitro in vivo correlation of CYP3A4 induction. Drug Metab Dispos. 2008;36:2355–70. "
              }
            },
            {
              "Name": "Emax",
              "Value": 3.2,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Buckley DB, Wiegand CM, Prentiss PL, Fahmi OA. Time-course of cytochrome P450 (CYP450) induction in cultured human hepatocytes: Evaluation of activity and mRNA expression profiles for six inducible CYP450 enzymes. ISSX. 2013"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Rae 2001",
          "Molecule": "CYP2E1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l"
            },
            {
              "Name": "Emax",
              "Value": 0.8
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Templeton 2011",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            },
            {
              "Name": "Emax",
              "Value": 9.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Assumed",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.985,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Dixit 2007",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.383,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Greiner 1999",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 2.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Greiner et al. 1999"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 822.94,
          "Unit": "g/mol"
        }
      ]
    },
    {
      "Name": "Digoxin",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "fitted",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 1.40017663,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Neuhoff (2013)",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.71,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Neuhoff 2013"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous Solubility",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 64.8,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Internet",
                "Method": "InVitro",
                "Description": "Drugbank"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Internet",
                "Method": "InVitro",
                "Description": "Drugbank"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "fitted",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 2.7627E-07,
              "Unit": "dm/min"
            }
          ]
        }
      ],
      "Permeability": [
        {
          "Name": "fitted",
          "Parameters": [
            {
              "Name": "Permeability",
              "Value": 1.0115E-05,
              "Unit": "dm/min"
            }
          ]
        }
      ],
      "Processes": [
        {
          "InternalName": "SpecificBinding",
          "DataSource": "Katz (2010)",
          "Molecule": "ATP1A2",
          "Parameters": [
            {
              "Name": "koff",
              "Value": 0.00098888,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Katz 2010"
              }
            },
            {
              "Name": "Kd",
              "Value": 25.6,
              "Unit": "nmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ]
        },
        {
          "InternalName": "LiverClearance",
          "DataSource": "Fitted",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (experiment)",
              "Value": 0.71
            },
            {
              "Name": "Lipophilicity (experiment)",
              "Value": 1.40017663,
              "Unit": "Log Units"
            },
            {
              "Name": "Plasma clearance",
              "Value": 0.0,
              "Unit": "ml/min/kg"
            },
            {
              "Name": "Specific clearance",
              "Value": 0.03758077,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Stephens (2001)",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 8.67,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 177.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 71.163,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ],
          "Description": "A transporter mediated unidirectional transfer of a compound across a cellular membrane is described as saturable process following Michaelis-Menten type kinetics. The corresponding kcat value is calculated from a specific Vmax as input value."
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "Steiness (1982)",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Steiness (1982)"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 780.93,
          "Unit": "g/mol",
          "ValueOrigin": {
            "Source": "Internet",
            "Method": "InVitro",
            "Description": "Drugbank"
          }
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Oral solution",
      "FormulationType": "Formulation_Dissolved"
    }
  ],
  "Protocols": [
    {
      "Name": "Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 28.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2008_Treatment_Rifampicin_300mg_BID_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 12.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Greiner1999_Treatment_Rifampicin_600mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 16.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 1.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 648.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 1.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 816.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        },
        {
          "Name": "Schema 3",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 1.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 984.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        },
        {
          "Name": "Schema 4",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 1.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 1320.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Larsen2007_Control_Digoxin_0.5mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2008_Treatment_Digoxin_0.25mg_PO_Day7",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.25,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Greiner1999_Treatment_Digoxin_1mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 8.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 240.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Greiner1999_Treatment_Digoxin_1mg_IV",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 8.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 240.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2008_Control_Digoxin_0.25mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.25,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2006_Control_Digoxin_0.4mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.4,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2006_Treatment_Digoxin_0.4mg_PO_Day7",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.4,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2006_Treatment_Rifampicin_300mg_BID_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Larsen2007_Treatment_Digoxin_0.5mg_PO_Day6",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Greiner1999_Control_Digoxin_1mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Greiner1999_Control_Digoxin_1mg_IV",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2007_Control_Digoxin_0.5mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2007_Treatment_Digoxin_0.5mg_PO_Day7",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley2007_Treatment_Rifampicin_300mg_BID_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kirby2012_Control_Digoxin_0.5mg_PO",
      "ApplicationType": "Oral",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 0.5,
          "Unit": "mg"
        },
        {
          "Name": "Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ]
    },
    {
      "Name": "Kirby2012_Treatment_Study1_Digoxin_0.5mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 324.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kirby2012_Treatment_Study2_Digoxin_0.5mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 336.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kirby2012_Treatment_Rifampicin_600mg_PO_study1",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Wiebe2020_Control_Digoxin_0.25mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.25,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Wiebe2020_Treatment_Digoxin_0.25mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.25,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Wiebe2020_Treatment_Rifampicin_600mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kirby2012_Treatment_Rifampicin_600mg_PO_study2",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 15.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Drescher2003_Control_Digoxin_1mg_IV",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Drescher2003_Treatment_Digoxin_1mg_IV",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 8.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 228.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Drescher2003_Treatment_Rifampicin_600mg_PO",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "ObserverSets": [
    {
      "Name": "Fold-change in concentration",
      "Observers": [
        {
          "Name": "Fold-change in concentration",
          "Dimension": "Dimensionless",
          "ContainerCriteria": [
            {
              "Tag": "Gallbladder",
              "Type": "Not"
            },
            {
              "Tag": "LumenSegment",
              "Type": "Not"
            }
          ],
          "Formula": {
            "Name": "Fold-change in concentration",
            "Formula": "Start_amount>0 ? Amount/Start_amount : 0",
            "References": [
              {
                "Alias": "Amount",
                "Dimension": "Amount",
                "Path": "..|..|MOLECULE"
              },
              {
                "Alias": "Start_amount",
                "Dimension": "Concentration (molar)",
                "Path": "..|..|MOLECULE|Start amount"
              }
            ],
            "Dimension": "Dimensionless"
          },
          "MoleculeList": {
            "ForAll": true
          },
          "Type": "Amount"
        }
      ]
    }
  ],
  "Simulations": [
    {
      "Name": "Gurley2008b_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2008_Treatment_Digoxin_0.25mg_PO_Day7|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2008_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2008_Treatment_Digoxin_0.25mg_PO_Day7",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley2008_Treatment_Rifampicin_300mg_BID_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2008b_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|Time",
              "Y": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2008b_Treatment\n2023-03-17 11:40"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Larsen2007_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 122.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 122.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 216.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Larsen2007_Treatment_Digoxin_0.5mg_PO_Day6|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
        },
        {
          "Scaling": "Log",
          "Path": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
        },
        {
          "Scaling": "Log",
          "Path": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
        },
        {
          "Scaling": "Log",
          "Path": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Larsen2007_Treatment_Digoxin_0.5mg_PO_Day6",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Larsen2007_Treatment_Rifampicin_600mg_PO_Day2-7",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Larsen2007_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)-Digoxin-Peripheral Venous Blood-Plasma-Individual",
              "X": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|Time",
              "Y": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|Individual",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nLarsen2007_Treatment\n2023-03-29 15:30"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Reitmann2011_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 649.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 1489.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 649.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_16|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_17|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_18|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_19|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_20|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_21|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_22|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_23|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_24|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_25|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_26|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_27|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_28|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)"
        },
        {
          "Scaling": "Log",
          "Path": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)"
        },
        {
          "Scaling": "Log",
          "Path": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)"
        },
        {
          "Scaling": "Log",
          "Path": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Reitman2011_Treatment_Digoxin_0.5mg_PO_Day28_Day35_Day42_Day56",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Reitman2011_Treatment_Rifampicin_600mg_PO_Day1-28",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Reitmann2011_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nReitmann2011_Treatment\n2023-04-06 16:06"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Gurley2008b_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2008_Control_Digoxin_0.25mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        },
        {
          "Scaling": "Log",
          "Path": "Gurley2008b_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2008_Control_Digoxin_0.25mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2008b_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|Time",
              "Y": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2008b_Control\n2023-03-17 11:33"
        }
      ]
    },
    {
      "Name": "Gurley2006_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2006_Treatment_Digoxin_0.4mg_PO_Day7|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2006_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2006_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2006_Treatment_Digoxin_0.4mg_PO_Day7",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley2006_Treatment_Rifampicin_300mg_BID_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2006_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2006_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|Time",
              "Y": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2006_Treatment\n2023-03-17 11:46"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Gurley2006_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2006_Control_Digoxin_0.4mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2006_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2006_Control_Digoxin_0.4mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2006_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|Time",
              "Y": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2006_Control\n2023-03-17 11:50"
        }
      ]
    },
    {
      "Name": "Larsen2007_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 216.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Larsen2007_Control_Digoxin_0.5mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Larsen2007_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Larsen2007_Control_Digoxin_0.5mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Larsen2007_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)-Digoxin-Peripheral Venous Blood-Plasma-Individual",
              "X": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|Time",
              "Y": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nLarsen2007_Control\n2023-03-17 12:03"
        }
      ]
    },
    {
      "Name": "Greiner1999_Digoxin-IV_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Greiner1999_Control_Digoxin_1mg_IV|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Control_Digoxin_1mg_IV"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-IV_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|Time",
              "Y": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGreiner1999_Digoxin-IV_Control\n2023-03-17 12:19"
        }
      ]
    },
    {
      "Name": "Greiner1999_Digoxin-PO_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Greiner1999_Control_Digoxin_1mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Control_Digoxin_1mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-PO_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|Time",
              "Y": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGreiner1999_Digoxin-PO_Control\n2023-03-17 12:20"
        }
      ]
    },
    {
      "Name": "Gurley2007_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2007_Control_Digoxin_0.5mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2007_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2007_Control_Digoxin_0.5mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2007_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|Time",
              "Y": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2007_Control\n2023-03-17 12:26"
        }
      ]
    },
    {
      "Name": "Gurley2007_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley2007_Treatment_Digoxin_0.5mg_PO_Day7|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley2007_Treatment_Rifampicin_300mg_BID_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Gurley2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley2007_Treatment_Digoxin_0.5mg_PO_Day7",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley2007_Treatment_Rifampicin_300mg_BID_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2007_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Gurley2007_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|Time",
              "Y": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGurley2007_Treatment\n2023-03-17 12:29"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Kirby2012_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)",
        "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 72.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kirby2012_Control_Digoxin_0.5mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Kirby2012_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)"
        },
        {
          "Scaling": "Log",
          "Path": "Kirby2012_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kirby2012_Control_Digoxin_0.5mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Kirby2012_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|Time",
              "Y": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|Time",
              "Y": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nKirby2012_Control\n2023-03-21 14:08"
        }
      ]
    },
    {
      "Name": "Wiebe2020_Control",
      "Model": "4Comp",
      "ObservedData": [
        "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)",
        "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 72.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Wiebe2020_Control_Digoxin_0.25mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|Kidney|Urine|Digoxin|Fraction excreted to urine"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Wiebe2020_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)"
        },
        {
          "Scaling": "Linear",
          "Path": "Wiebe2020_Control|Organism|Kidney|Urine|Digoxin|Fraction excreted to urine",
          "ObservedData": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Wiebe2020_Control_Digoxin_0.25mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            },
            {
              "Unit": "",
              "Dimension": "Fraction",
              "Type": "Y2",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Dash",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "Wiebe2020_Control|Organism|Kidney|Urine|Digoxin|Fraction excreted to urine",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "Dash"
              }
            },
            {
              "Name": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)-Digoxin-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|Time",
              "Y": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|GeometricMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Wiebe2020_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)-Digoxin-Kidney-Urine-GeometricMean",
              "X": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|Time",
              "Y": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Digoxin|GeometricMean",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "Bottom",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nWiebe2020_Control\n2023-03-23 15:46"
        }
      ]
    },
    {
      "Name": "Wiebe2020_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)",
        "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 72.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Wiebe2020_Treatment_Digoxin_0.25mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Wiebe2020_Treatment_Rifampicin_600mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
        "Organism|Kidney|Urine|Digoxin|Fraction excreted to urine"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Wiebe2020_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)"
        },
        {
          "Scaling": "Linear",
          "Path": "Wiebe2020_Treatment|Organism|Kidney|Urine|Digoxin|Fraction excreted to urine",
          "ObservedData": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Wiebe2020_Treatment_Digoxin_0.25mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Wiebe2020_Treatment_Rifampicin_600mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            },
            {
              "Unit": "",
              "Dimension": "Fraction",
              "Type": "Y2",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Dash",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)-Digoxin-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|Time",
              "Y": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|GeometricMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Wiebe2020_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3
              }
            },
            {
              "Name": "Digoxin-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "Wiebe2020_Treatment|Organism|Kidney|Urine|Digoxin|Fraction excreted to urine",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "Dash"
              }
            },
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Wiebe2020_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)-Digoxin-Kidney-Urine-GeometricMean",
              "X": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|Time",
              "Y": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Digoxin|GeometricMean",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "Bottom",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nWiebe2020_Treatment\n2023-03-23 15:47"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Greiner1999_Digoxin-IV_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 536.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 248.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 536.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Greiner1999_Treatment_Digoxin_1mg_IV|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_16|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Treatment_Digoxin_1mg_IV"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Treatment_Rifampicin_600mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 225.5299,
              "Max": 279.7912,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0003268924,
              "Max": 11.46183,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|Time",
              "Y": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGreiner1999_Digoxin-IV_Treatment\n2023-03-30 09:04"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Greiner1999_Digoxin-PO_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 248.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 248.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 536.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Greiner1999_Treatment_Digoxin_1mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_16|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Greiner1999_Treatment_Rifampicin_600mg_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Treatment_Digoxin_1mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Greiner1999_Treatment_Rifampicin_600mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 234.8228,
              "Max": 317.691,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0001140183,
              "Max": 9.986885,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Greiner1999_Digoxin-PO_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|Time",
              "Y": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nGreiner1999_Digoxin-PO_Treatment\n2023-03-30 10:11"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Kirby2012_Study1_StaggeredAdministration_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 324.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 324.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 326.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 326.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 396.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study1|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Study1_Digoxin_0.5mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Kirby2012_Study1_StaggeredAdministration_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kirby2012_Treatment_Study1_Digoxin_0.5mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Kirby2012_Treatment_Rifampicin_600mg_PO_study1",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Kirby2012_Study1_StaggeredAdministration_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Kirby2012_Study1_StaggeredAdministration_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|Time",
              "Y": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nKirby2012_Study1_StaggeredAdministration_Treatment\n2023-03-30 11:09"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Kirby2012_Study2_SimultaneousAdministration_Treatment",
      "Model": "4Comp",
      "ObservedData": [
        "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 324.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 324.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 336.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 336.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 408.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Rifampicin_600mg_PO_study2|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kirby2012_Treatment_Study2_Digoxin_0.5mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Kirby2012_Study2_SimultaneousAdministration_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)"
        }
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kirby2012_Treatment_Study2_Digoxin_0.5mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Kirby2012_Treatment_Rifampicin_600mg_PO_study2",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Kirby2012_Study2_SimultaneousAdministration_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Kirby2012_Study2_SimultaneousAdministration_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)-Digoxin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|Time",
              "Y": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nKirby2012_Study2_SimultaneousAdministration_Treatment\n2023-03-30 11:06"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "Drescher2003_Digoxin-IV_Control",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Drescher2003_Control_Digoxin_1mg_IV|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Drescher2003_Control_Digoxin_1mg_IV"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Drescher2003_Digoxin-IV_Control|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nDrescher2003_Digoxin-IV_Control\n2023-03-30 13:45"
        }
      ]
    },
    {
      "Name": "Drescher2003_Digoxin-IV_Treatment",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 236.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 236.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 336.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Drescher2003_Treatment_Digoxin_1mg_IV|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Drescher2003_Treatment_Rifampicin_600mg_PO|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Undefined Liver|Reference concentration",
          "Value": 1.0,
          "Unit": "µmol/l"
        },
        {
          "Path": "Undefined Liver|t1/2 (intestine)",
          "Value": 1380.0,
          "Unit": "min"
        },
        {
          "Path": "Undefined Liver|t1/2 (liver)",
          "Value": 2160.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Digoxin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_PERMEABILITY"
            },
            {
              "AlternativeName": "fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Total Hepatic Clearance-Fitted",
              "SystemicProcessType": "Hepatic"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Stephens (2001)",
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "MoleculeName": "OATP1B1"
            },
            {
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-Steiness (1982)",
              "SystemicProcessType": "GFR"
            },
            {
              "Name": "ATP1A2-Katz (2010)",
              "MoleculeName": "ATP1A2"
            },
            {
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Drescher2003_Treatment_Digoxin_1mg_IV"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "MoleculeName": "CYP3A4"
            },
            {
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "Glomerular Filtration-GFR",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Drescher2003_Treatment_Rifampicin_600mg_PO",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Digoxin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Drescher2003_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Digoxin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Drescher2003_Digoxin-IV_Treatment|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Rifampicin-Digoxin-DDI\nDrescher2003_Digoxin-IV_Treatment\n2023-03-30 13:49"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Hanke 2021",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16326.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/17079360/"
        },
        {
          "Name": "Source",
          "Value": "Fig 1b"
        },
        {
          "Name": "Grouping",
          "Value": "Digoxin + Rifampicin"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 20.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 146.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                4.764713E-05,
                9.52661649E-05,
                0.000595294463,
                0.000595237943,
                0.0005237812,
                0.0005952666,
                0.0004404759,
                0.000333305215,
                0.0002023529,
                0.0001429133
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0002625786,
            0.001001376,
            0.00141866,
            0.00150297594,
            0.001527797,
            0.001326398,
            0.001125,
            0.0008293464,
            0.000559551932
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2007 - Digoxin + Rifampicin - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          146.0,
          146.33,
          146.67,
          147.0,
          147.5,
          148.0,
          148.5,
          149.0,
          150.0,
          152.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16325.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/17079360/"
        },
        {
          "Name": "Source",
          "Value": "Fig 1b"
        },
        {
          "Name": "Grouping",
          "Value": "control"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 20.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                9.52380942E-05,
                0.0003095238,
                0.000619047438,
                0.000547618954,
                0.0005714562,
                0.0005356864,
                0.0004404758,
                0.0004047903,
                0.000190476188,
                0.0001071149
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0004054358,
            0.001548939,
            0.00218056515,
            0.00218154816,
            0.001896844,
            0.001659732,
            0.00131547591,
            0.0009484221,
            0.000630980358
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2007 - control - Digoxin - PO - 0.5 mg - serum - agg. (n=20)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.33,
          0.6,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 227.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2008b"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18214850"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 18.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 146.0
        },
        {
          "Name": "Formulation",
          "Value": "0.25 mg, Lanoxin®, GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.0001818182,
                0.0003127273,
                0.000280000066,
                0.0002363636,
                0.00028,
                0.000261818117,
                0.000232727311,
                0.0001709091,
                8.363639E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.00018909089,
            0.0005527273,
            0.0007018182,
            0.00064,
            0.00064,
            0.0005927272,
            0.0005527273,
            0.000443636382,
            0.0002836364
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2008b - with Perpetrator (Rifampicin) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          146.0,
          146.33,
          146.67,
          147.0,
          147.5,
          148.0,
          148.5,
          149.0,
          150.0,
          152.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 226.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2008b"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18214850"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 18.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "0.25 mg, Lanoxin®, GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.0001054546,
                0.00037818178,
                0.000316363818,
                0.0003054546,
                0.0003054546,
                0.0002654545,
                0.0002763636,
                0.0001781818,
                0.0001127273
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0001854545,
            0.00076,
            0.00110181794,
            0.001090909,
            0.0008836364,
            0.0007927273,
            0.00072363636,
            0.0005127273,
            0.00032
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2008b - Control (Perpetrator Placebo) - Digoxin - PO - 0.25 mg - Serum - agg. (n=18)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.33,
          0.67,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 396.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1c"
        },
        {
          "Name": "Grouping",
          "Value": "Week 0 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 649.0
        },
        {
          "Name": "Formulation",
          "Value": "Tablet (2x 0.25 mg)"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.000416293,
            0.00153019407,
            0.002138715,
            0.001973692,
            0.001258595,
            0.000962929742
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          649.25,
          649.5,
          649.75,
          650.0,
          651.0,
          652.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 397.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1c"
        },
        {
          "Name": "Grouping",
          "Value": "Week 1 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 817.0
        },
        {
          "Name": "Formulation",
          "Value": "Tablet (2x 0.25 mg)"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            6.56203338E-05,
            0.0005572496,
            0.000859790656,
            0.0009423019,
            0.0008357249,
            0.0007738416
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          817.25,
          817.5,
          817.75,
          818.0,
          819.0,
          820.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 316.0
        },
        {
          "Name": "Study Id",
          "Value": "Kirby 2012"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/22190694"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Study 2 - Simultaneous Administration with RIF"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 336.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanoxin, 0.25-mg tablets; GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                0.0001988234,
                0.001239679,
                0.00124941,
                0.001136078,
                0.001000014,
                0.0007099802,
                9.942949E-06,
                0.0002057806,
                0.0001634131,
                0.000138546209,
                0.0001126506,
                8.719207E-05,
                8.238752E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.0003041424,
            0.001254474,
            0.00146606693,
            0.00167731789,
            0.001529732,
            0.00116867106,
            0.000706692867,
            0.0004619717,
            0.0003084827,
            0.000251188583,
            0.000200234281,
            0.0001435235,
            0.000135615
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Kirby 2012 - Study 2 - Simultaneous Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          336.25,
          336.5,
          336.75,
          337.0,
          337.5,
          338.0,
          339.0,
          340.0,
          341.0,
          342.0,
          344.0,
          348.0,
          359.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 315.0
        },
        {
          "Name": "Study Id",
          "Value": "Kirby 2012"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/22190694"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Study 2 - Simultaneous Administration Control"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanoxin, 0.25-mg tablets; GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                0.0003487233,
                0.0004864858,
                0.000442996883,
                0.000589713862,
                0.000317187,
                0.0001930383,
                0.0002822253,
                0.000137600189,
                0.000133109308,
                7.73498541E-05,
                0.000119135606,
                9.726107E-05,
                8.646376E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.0003579696,
            0.0004718958,
            0.000600428844,
            0.0009184952,
            0.001058316,
            0.000785931246,
            0.0005795313,
            0.0003761704,
            0.0002793533,
            0.00020599,
            0.0001642043,
            0.0001318257,
            0.0001254474
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Kirby 2012 - Study 2 - Simultaneous Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          12.0,
          23.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 191.0
        },
        {
          "Name": "Study Id",
          "Value": "Greiner 1999"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/10411543"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 248.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.0002435162,
                0.0007826411,
                0.000730426866,
                0.0007652093,
                0.00083481404,
                0.000591338438,
                0.000626080961,
                0.000521733367,
                0.000521693146,
                0.000469560619,
                0.0004347378,
                0.0002435162,
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.000399148616,
            0.001494023,
            0.001997518,
            0.002188417,
            0.00230971118,
            0.002239743,
            0.002255884,
            0.00206333,
            0.00192295,
            0.00162484008,
            0.0014459251,
            0.0008099182,
            0.0006086895
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Greiner 1999 - po with Perpetrator (Rifampicin) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          248.0,
          248.17,
          248.33,
          248.5,
          248.58,
          248.67,
          248.75,
          249.0,
          249.25,
          249.5,
          250.0,
          251.0,
          253.0,
          255.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 190.0
        },
        {
          "Name": "Study Id",
          "Value": "Greiner 1999"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/10411543"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "po Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.00133911707,
                0.002626101,
                0.002347843,
                0.002121678,
                0.001826029,
                0.001669589,
                0.001252202,
                0.000869556447,
                0.0007826815,
                0.0006260805,
                0.0003304317,
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.00149479,
            0.00377226062,
            0.004606188,
            0.00497103762,
            0.004970594,
            0.004865804,
            0.00437760074,
            0.00371552818,
            0.00324467616,
            0.002442223,
            0.00160244491,
            0.0009664384,
            0.0007303871
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Greiner 1999 - po Control (Perpetrator Placebo) - Digoxin - PO - 1 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.17,
          0.33,
          0.5,
          0.58,
          0.67,
          0.75,
          1.0,
          1.25,
          1.5,
          2.0,
          3.0,
          5.0,
          7.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 336.0
        },
        {
          "Name": "Study Id",
          "Value": "Larsen 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17365992"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "typical representative"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Oral soultion"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 4E-05
          },
          "Values": [
            1.7730501E-05,
            0.0002130699,
            0.0004970517,
            0.0007721783,
            0.00108273607,
            0.001721337,
            0.001987589,
            0.002067822,
            0.001669341,
            0.001492472,
            0.00132446806,
            0.00119193492,
            0.001041692,
            0.0009268794,
            0.0009273556,
            0.001051864,
            0.0008750152,
            0.0008045289,
            0.0007251874,
            0.000602846965
          ],
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Larsen 2007 - Control (Perpetrator Placebo) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.166666672,
          0.333333343,
          0.5,
          0.6666667,
          0.8333333,
          1.0,
          1.25,
          1.5,
          1.75,
          2.0,
          2.25,
          2.5,
          2.75,
          3.0,
          3.25,
          3.5,
          3.75,
          4.0,
          5.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 337.0
        },
        {
          "Name": "Study Id",
          "Value": "Larsen 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17365992"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "typical representative"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 144.0
        },
        {
          "Name": "Formulation",
          "Value": "Oral soultion"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 4E-05
          },
          "Values": [
            0.0001241135,
            0.000611995871,
            0.0008073252,
            0.001268622,
            0.001366413,
            0.00128692994,
            0.001287224,
            0.001367457,
            0.001332452,
            0.00120877393,
            0.001164894,
            0.00109440694,
            0.001015096,
            0.0009445897,
            0.0009007497,
            0.000785896729,
            0.000786352553,
            0.0007424721,
            0.00070744683,
            0.0005851064
          ],
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Larsen 2007 - with Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Serum - typical (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          144.0,
          144.166672,
          144.333328,
          144.5,
          144.666672,
          144.833328,
          145.0,
          145.25,
          145.5,
          145.75,
          146.0,
          146.25,
          146.5,
          146.75,
          147.0,
          147.25,
          147.5,
          147.75,
          148.0,
          149.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 398.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1c"
        },
        {
          "Name": "Grouping",
          "Value": "Week 2 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 985.0
        },
        {
          "Name": "Formulation",
          "Value": "Tablet (2x 0.25 mg)"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.000106875894,
            0.000608819129,
            0.001028251,
            0.001217339,
            0.001028251,
            0.000849476841
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          985.25,
          985.5,
          985.75,
          986.0,
          987.0,
          988.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 399.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1c"
        },
        {
          "Name": "Grouping",
          "Value": "Week 4 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 1321.0
        },
        {
          "Name": "Formulation",
          "Value": "Tablet (2x 0.25 mg)"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.000127503692,
            0.00080822123,
            0.001145142,
            0.001193274,
            0.001007623,
            0.0008150972
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Digoxin - PO - 0.5 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          1321.25,
          1321.5,
          1321.75,
          1322.0,
          1323.0,
          1324.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16301.0
        },
        {
          "Name": "Study Id",
          "Value": "Wiebe 2020"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/32504272/"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Digoxin (Cocktail) + Rifampin"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.00063649856,
            0.002397435,
            0.001983665,
            0.001503887,
            0.001075587,
            0.000803643255,
            0.00063649856,
            0.000496824,
            0.0004232357,
            0.0003821893,
            0.000345123583,
            0.000285559217,
            0.000257865,
            0.0002468341
          ],
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.33,
          0.67,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0,
          12.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16302.0
        },
        {
          "Name": "Study Id",
          "Value": "Wiebe 2020"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/32504272/"
        },
        {
          "Name": "Source",
          "Value": "Table S1"
        },
        {
          "Name": "Grouping",
          "Value": "Digoxin (Cocktail) + Rifampin"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "human"
        },
        {
          "Name": "Organ",
          "Value": "Kidney"
        },
        {
          "Name": "Compartment",
          "Value": "Urine"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Digoxin|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.3082
          ],
          "Dimension": "Fraction"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Wiebe 2020 - Digoxin (Cocktail) + Rifampin - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          36.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16322.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/16221754/"
        },
        {
          "Name": "Source",
          "Value": "Fig 1b"
        },
        {
          "Name": "Grouping",
          "Value": "day 7 plasma + Rifampin"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.4 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 146.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                1.51684E-05,
                0.0001897539,
                0.0001366586,
                0.0002884259,
                0.00034914742,
                0.000318821985,
                0.000227728509,
                0.000136646908,
                4.556501E-05,
                6.07330767E-05,
                4.55528825E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0001363011,
            0.000341163832,
            0.0009784985,
            0.001737288,
            0.00201773,
            0.002070206,
            0.00160658709,
            0.001013292,
            0.0007463732,
            0.000447819184
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2006 - day 7 plasma + Rifampin - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          146.0,
          146.25,
          146.33,
          146.5,
          146.67,
          147.0,
          147.5,
          148.0,
          149.0,
          150.0,
          152.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16321.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/16221754/"
        },
        {
          "Name": "Source",
          "Value": "Fig 1b"
        },
        {
          "Name": "Grouping",
          "Value": "day 1 plasma"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.4 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                7.57824E-06,
                1.190603E-08,
                0.0001138285,
                0.0002732334,
                0.000409868226,
                0.000318762817,
                0.0001442487,
                9.868383E-05,
                3.036058E-05,
                3.03606375E-05,
                3.79745979E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0001894441,
            0.0004322337,
            0.002063891,
            0.002230672,
            0.002989258,
            0.00250283279,
            0.001659718,
            0.0009829192,
            0.000761529664,
            0.000531287049
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Gurley 2006 - day 1 plasma - Digoxin - PO - 0.4 mg - serum - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.25,
          0.33,
          0.5,
          0.67,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16304.0
        },
        {
          "Name": "Study Id",
          "Value": "Wiebe 2020"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/32504272/"
        },
        {
          "Name": "Source",
          "Value": "Table S1"
        },
        {
          "Name": "Grouping",
          "Value": "Digoxin + Placebo"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "human"
        },
        {
          "Name": "Organ",
          "Value": "Kidney"
        },
        {
          "Name": "Compartment",
          "Value": "Urine"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Digoxin|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.26
          ],
          "Dimension": "Fraction"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Urine - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          36.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 16303.0
        },
        {
          "Name": "Study Id",
          "Value": "Wiebe 2020"
        },
        {
          "Name": "Reference",
          "Value": "https://pubmed.ncbi.nlm.nih.gov/32504272/"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Digoxin + Placebo"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.25 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Path": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.0002897513,
            0.0008274114,
            0.001029576,
            0.000971274043,
            0.000725704,
            0.0006182145,
            0.00058320706,
            0.000468690385,
            0.0003992692,
            0.0003352096,
            0.000285559217,
            0.0002328566,
            0.0001926682,
            0.0002042333
          ],
          "Dimension": "Concentration (molar)",
          "Unit": "µmol/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Wiebe 2020 - Digoxin + Placebo - Digoxin - PO - 0.25 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.33,
          0.67,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0,
          12.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 193.0
        },
        {
          "Name": "Study Id",
          "Value": "Greiner 1999"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/10411543"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1b"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 248.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanicor, Boehringer Ingelheim"
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.001415098,
                0.001768868,
                0.001768866,
                0.00127358607,
                0.00134434493,
                0.001061323,
                0.0007783017,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.0129481088,
            0.01740566,
            0.02073113,
            0.0152830193,
            0.0125235906,
            0.0107547194,
            0.007924528,
            0.005872642,
            0.00474056555,
            0.00332547212,
            0.00169811293,
            0.001061321,
            0.0008490566
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Greiner 1999 - iv with Perpetrator (Rifampicin) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          248.0,
          248.17,
          248.33,
          248.5,
          248.58,
          248.67,
          248.75,
          249.0,
          249.25,
          249.5,
          250.0,
          251.0,
          253.0,
          255.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 192.0
        },
        {
          "Name": "Study Id",
          "Value": "Greiner 1999"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/10411543"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1b"
        },
        {
          "Name": "Grouping",
          "Value": "iv Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanicor, Boehringer Ingelheim"
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                "NaN",
                0.00113207893,
                0.0014151,
                0.005306601,
                0.001839622,
                0.00134433806,
                0.00106131693,
                0.0009905653,
                0.0007783017,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.01224057,
            0.01853773,
            0.0245518889,
            0.01648585,
            0.0140801892,
            0.01209906,
            0.008278303,
            0.00643867953,
            0.00516509358,
            0.00360848987,
            0.001910377,
            0.00120283,
            0.001061321
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Greiner 1999 - iv Control (Perpetrator Placebo) - Digoxin - IV - 1 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0,
          0.17,
          0.33,
          0.5,
          0.58,
          0.67,
          0.75,
          1.0,
          1.25,
          1.5,
          2.0,
          3.0,
          5.0,
          7.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 313.0
        },
        {
          "Name": "Study Id",
          "Value": "Kirby 2012"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/22190694"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Study 1 - Staggered Administration Control"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanoxin, 0.25-mg tablets; GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                9.752804E-05,
                0.000723545149,
                0.0007444199,
                0.0006876103,
                0.00073316443,
                0.000660943,
                0.0003409513,
                0.000139705589,
                0.0001403453,
                0.0001309279,
                0.000139394513,
                9.084606E-05,
                9.015575E-05,
                6.757754E-05,
                6.283225E-05,
                4.96045068E-05,
                4.49341969E-05,
                6.122351E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.000281404617,
            0.0006921389,
            0.000887119735,
            0.00101517409,
            0.001121529,
            0.001129996,
            0.000907985435,
            0.0005898876,
            0.000454265362,
            0.000367607718,
            0.0003358566,
            0.0002864542,
            0.0002540434,
            0.0002069907,
            0.000204087308,
            0.0002026509,
            0.0001835708,
            0.0001822788
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Kirby 2012 - Study 1 - Staggered Administration Control - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          12.0,
          23.0,
          26.0,
          28.0,
          30.0,
          34.0,
          47.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 314.0
        },
        {
          "Name": "Study Id",
          "Value": "Kirby 2012"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/22190694"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Study 1 - Staggered Administration with RIF"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Digoxin"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 324.0
        },
        {
          "Name": "Formulation",
          "Value": "Lanoxin, 0.25-mg tablets; GlaxoSmithKline"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Path": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 780.93
              },
              "Values": [
                4.2856158E-05,
                0.0003189535,
                0.000427265622,
                0.0003458263,
                0.0002766479,
                0.0004001186,
                0.0002483962,
                0.000170042,
                0.000115091694,
                6.134301E-05,
                5.95489E-05,
                5.28652454E-05,
                7.556243E-05,
                3.376082E-05,
                4.966411E-05,
                4.51809319E-05,
                2.30697515E-05,
                3.616446E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Path": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Digoxin|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 780.93
          },
          "Values": [
            0.0002211628,
            0.0002775071,
            0.00038179,
            0.0005290142,
            0.00079820503,
            0.0007873316,
            0.00067908637,
            0.000490651466,
            0.0003725253,
            0.0002909686,
            0.00023400801,
            0.0002084579,
            0.0002129222,
            0.000148518,
            0.0001662872,
            0.000138389893,
            0.000130787012,
            0.000128952408
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Kirby 2012 - Study 1 - Staggered Administration with RIF - Digoxin - PO - 0.5 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          324.25,
          324.5,
          324.75,
          325.0,
          325.5,
          326.0,
          327.0,
          328.0,
          329.0,
          330.0,
          332.0,
          336.0,
          347.0,
          350.0,
          352.0,
          354.0,
          358.0,
          371.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    }
  ]
}